Contest Catch the Monkey 12.06.2021
With a performance of 37.298% Vassago1 won our stockpicking contest Catch the Monkey 12.06.2021, beating skyrockerZoe who finished second. With a performance of 7.396% KongVestor only managed to reach position 13.
We discuss all securities, matching the rule For 5 securities, where you also told the community the pros and cons you get 1% extra performance
The most predictions written for this stockpicking contest were for AMC Entertainment Holdings Inc., followed by Tesla Inc and Bitcoin. 10 contestants picked AMC Entertainment Holdings Inc., followed by 8 predictions for Tesla Inc and 8 for Bitcoin. Global_Player had the best individual performance with the prediction Buy Washington Prime Group Inc., followed by AlexKlar with Buy AMC Entertainment Holdings Inc. and skyrockerZoe with Buy 1847 Goedeker Inc.. The prediction Buy Washington Prime Group Inc. achieved a performance of 212.849%. 77.158% are in the books for the prediction Buy AMC Entertainment Holdings Inc., and 65.161% for Buy 1847 Goedeker Inc..
| Name | Prediction | Start price | Perf. (%) |
|---|---|---|---|
| CENIT AG | buy | €14.00 | 0.714% |
| Exact Sciences | buy | €91.24 | 10.368% |
| Getinge AB B | buy | €28.89 | 6.231% |
| Delivery Hero SE | sell | €111.10 | 0.090% |
| Name | Prediction | Start price | Perf. (%) |
|---|---|---|---|
| Aroundtown SA | buy | €7.06 | 0.227% |
| GFT Technologies AG | sell | €20.55 | 4.380% |
| Airbus Group SE | buy | €110.04 | 2.217% |
| Name | Prediction | Start price | Perf. (%) |
|---|---|---|---|
| Tradegate AG | buy | €123.00 | -0.407% |
| alstria office REIT-AG | buy | €15.01 | 3.198% |
| Dr. Hoenle AG | buy | €48.05 | 0.000% |
| MorphoSys AG | buy | €65.80 | 2.184% |
| Name | Prediction | Start price | Perf. (%) |
|---|---|---|---|
| Square Inc. | sell | €174.04 | 4.103% |
| Name | Prediction | Start price | Perf. (%) |
|---|---|---|---|
| Xiaomi Corp. | buy | €3.03 | -1.273% |
| Name | Prediction | Start price | Perf. (%) |
|---|---|---|---|
| Paycom Software | buy | €265.60 | 5.723% |
Top Performer
| Prediction | Security | User | Perf. (%) |
|---|---|---|---|
| B | Washington Prime Group Inc. | Global_Player | 212.849% |
| B | AMC Entertainment Holdings Inc. | AlexKlar | 77.158% |
| B | 1847 Goedeker Inc. | skyrockerZoe | 65.161% |
| B | 1847 Goedeker Inc. | quelbe60 | 65.161% |
| B | The9 Ltd ADR | quelbe60 | 64.103% |
| Prediction | Security | User | Perf. (%) |
|---|---|---|---|
| S | windeln.de SE | Ilyo | -48.936% |
| S | windeln.de SE | tbackenh | -32.235% |
| S | Bank of Ayudhya -fgn- | nvestor | -29.091% |
| S | Horizen | blaugold | -28.559% |
| S | Zcash | blaugold | -27.445% |
Comments
Meine aducanumab-Wette ist gut aufgegangen, dass war der Grundstein des Erfolgs. 📈
Sie sehen sie nur als Beobachtungsaktie
- Ende April gab Adverum bekannt, dass seine experimentelle Gentherapie für diabetisches Makulaödem (DME), bekannt als ADVM-022, in seiner laufenden Mid-Stage-Studie auf einen ernsthaften Haken gestoßen ist. Insbesondere soll ein Patient in der Studie Hypotonie (niedriger Augeninnendruck) und Sehverlust im behandelten Auge entwickelt haben, was das Unternehmen dazu zwang, sein klinisches Programm für ADVM-022 zu überdenken.
- Als direkte Folge dieses unerwarteten klinischen Rückschlags veröffentlichte Sonic Fund II, ein Hauptaktionär des Unternehmens, eine vernichtende Pressemitteilung, in der die Ernennung von drei neuen Vorstandsmitgliedern zur Überwachung der klinischen Entwicklung von ADVM-022 gefordert wurde.